These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19563269)
1. Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119. Norman P Expert Opin Ther Pat; 2009 Aug; 19(8):1157-63. PubMed ID: 19563269 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of WO-2012085582 and WO-2012085583 two identified MABAs: backups to AZD-2115? Norman P Expert Opin Ther Pat; 2012 Nov; 22(11):1377-83. PubMed ID: 22917191 [TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the clinical management of COPD. Bronchodilatators]. SPLF. Société de Pneumologie de Langue Française Rev Mal Respir; 2003 Jun; 20(3 Pt 2):S32-5. PubMed ID: 12910092 [No Abstract] [Full Text] [Related]
9. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma. Kim D; Glaum M; Lockey R Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072 [TBL] [Abstract][Full Text] [Related]
10. AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653. Norman P Expert Opin Ther Pat; 2009 Nov; 19(11):1629-33. PubMed ID: 19586423 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
12. Current options in the treatment of acute bronchospasm. Berger WE Postgrad Med; 2005 Dec; 118(6 Suppl Acute):18-26. PubMed ID: 19667712 [TBL] [Abstract][Full Text] [Related]
13. [Mechanism of B2-agonists action and safety aspects]. Chorostowska-Wynimko J Pol Merkur Lekarski; 2002 Jun; 12(72):441-4. PubMed ID: 12362656 [TBL] [Abstract][Full Text] [Related]
14. Arformoterol (Brovana) for COPD. Med Lett Drugs Ther; 2007 Jul; 49(1264):53-5. PubMed ID: 17595597 [No Abstract] [Full Text] [Related]
15. Update on the management of COPD. Colby J; Goldman M Conn Med; 2009 Apr; 73(4):217-21. PubMed ID: 19413083 [No Abstract] [Full Text] [Related]
16. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease. Wang ZL Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229 [No Abstract] [Full Text] [Related]
18. Salmeterol: a long acting bronchodilator. Bhadoria DP; Bhadoria P J Postgrad Med; 1995; 41(1):24-6. PubMed ID: 10740700 [No Abstract] [Full Text] [Related]
19. Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease. Hughes AD; Jones LH Future Med Chem; 2011 Oct; 3(13):1585-605. PubMed ID: 21942250 [TBL] [Abstract][Full Text] [Related]
20. The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPD. Brown AD; Bunnage ME; Glossop PA; Holbrook M; Jones RD; Lane CA; Lewthwaite RA; Mantell S; Perros-Huguet C; Price DA; Webster R Bioorg Med Chem Lett; 2007 Nov; 17(22):6188-91. PubMed ID: 17897826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]